ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 023,04
0,33%
Dow Jones
38 852,27
0,00%
DAX
18 290,46
0,65%
Brent Oil
82,915
-0,67%
Bitcoin
63 631,21
0,74%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BriaCell Therapeutics Corporation (BCTX)

  7. BriaCell Therapeutics Corporation (BCTX) Actualités

BCTX BriaCell Therapeutics Corporation

2,21
-0,06 (-2,64%)
Avant marché
Dernière mise à jour : 14:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
BriaCell Therapeutics Corporation BCTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,06 -2,64% 2,21 14:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,27
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202414:00GLOBEBriaCell Announces Oral and Poster Presentations at ASCO..
10/4/202414:00GLOBEBriaCell 2024 AACR Preclinical Poster Confirms Strong..
09/4/202414:00GLOBEBriaCell Showcases Data Demonstrating Unmatched..
07/3/202414:00GLOBEBriaCell Receives and Executes Letter of Intent to Advance..
06/3/202414:00GLOBEBriaCell to Present Clinical Data in Central Nervous System..
27/2/202414:00GLOBEBriaCell Provides Update on Alleged Illegal Trading of..
07/2/202414:00GLOBEBriaCell Announces Strong Clinical Data in Breast Cancer..
06/2/202414:30GLOBEBreaking Ground in Prostate Cancer: BriaCell Announces Lead..
01/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
31/1/202423:24EDGAR2Form 8-K - Current report
31/1/202404:48GLOBEBriaCell Therapeutics Corp. Announces Results of Shareholder..
22/1/202423:00EDGAR2Form S-3 - Registration statement under Securities Act of..
09/1/202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
04/1/202414:45GLOBEBriaCell Images Confirm Robust Anti-Tumor Activity in..
28/12/202314:55GLOBEBriaCell Reports 71% Central Nervous System Response Rate in..
20/12/202322:05EDGAR2Form 8-K - Current report
20/12/202314:40GLOBEBriaCell Reports Unprecedented Preliminary Survival and..
14/12/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/12/202323:00EDGAR2Form 8-K - Current report
06/12/202315:31GLOBEBriaCell Highlights Outstanding Topline Survival and..
06/12/202315:00GLOBEBriaCell 2023 SABCS Posters Confirm Activation of..
30/11/202313:00EDGAR2Form 8-K - Current report
30/11/202313:00GLOBEBriaCell Records New Responder with Remarkable Improvement..
03/11/202313:31GLOBEBriaCell Reports Unprecedented Anti-Tumor Activity of its..
25/10/202315:15GLOBEBriaCell Forms Medical Advisory Board of Distinguished..
20/10/202315:15GLOBEOctober is Breast Cancer Awareness Month – BriaCell is..
18/10/202315:00GLOBEBriaCell Announces Presentations at the 2023 Society for the..
11/10/202315:10GLOBEBriaCell To Host Virtual Key Opinion Leader Event on..
04/10/202315:00GLOBEBriaCell Partners with New York Cancer & Blood Specialists..
03/10/202315:00GLOBEBriaCell Initiates Pivotal Phase 3 Study of Bria-IMT™ in..
08/9/202313:00GLOBEBriaCell Reports Benchmark-Beating Patient Survival and..
31/8/202317:54GLOBEBriaCell Therapeutics Corp. Announces Closing of Plan of..
31/8/202314:21GLOBEBriaCell Accepts Letter of Intent from Weill Cornell..
25/8/202320:33GLOBEBriaCell Receives Court Approval for the Share Arrangement..
18/8/202318:21GLOBEBriaCell Therapeutics Corp. Announces Voting Results From..
16/8/202314:36GLOBEBriaCell Awarded National Cancer Institute Grant to Advance..
27/6/202315:37APSNews Brief: BriaCell Therapeutics Corp.
27/6/202314:05GLOBEFDA Approves BriaCell’s Pivotal Registrational Study Design..
25/5/202315:00GLOBEBriaCell Enters Definitive Arrangement Agreement for the..
19/5/202317:38GLOBEBriaCell Closes $4 Million Strategic Investment by Prevail..
15/5/202314:00GLOBEBriaCell Announces $4 Million Strategic Investment and..

Dernières Valeurs Consultées

NASDAQ
BCTX
BriaCell Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés